Saturday, April 26, 2025
A- A A+

Directors Desk

Presently, IUCBR & SSH is planned as a top-notch advanced academic-research and training center in basic applied biomedical sciences to address changing biomedica research needs of emerging healthcare problems in Kerala. We have established basic & applied laboratory facilities that are globally competitive. It is currently providing advanced research facilities to investigate the molecular pathology of neglected diseases, and healthcare issues emerging from environmental, genetic and epigenetic causes.

Scientific facilities are established to investigate pathophysiology of debilitating geriatric neurodegenerative diseases, rare diseases of the nervous system in children and developmental neuropsychiatric diseases, to diagnose and research on new and fatal communicable diseases, including viral infections. These projects have attracted grant-in-aid supports from agencies in India and abroad. An advanced animal care and breeding facility is completed, where traditional and individually ventilated caging systems for housing wild-type and transgenic laboratory animals will be created and maintained. IUCBR & SSH strives to utilize the diverse and vast resources of endemic medicinal plants of Kerala for modern drug discovery, and for newer formulations.

The institute conducts PhD programs in trans-disciplinary areas, and awards degree through Mahatma Gandhi University under the Faculty of Science and Modern Medicine.

The state-of-the-art research facilities created will be effectively utilized for production of clinical research materials including genetically modified cell lines and transgenic animals; invention of drugs, formulations, and delivery vehicles: publication of articles in high impact journals and in books; generating patents, and for translation into products. During the past three years, more than eighty million rupees commitments are received by IUCBR & SSH as grant-in-aid projects.

IUCBR & SSH is committed to diagnose and report on SARS-CoV-2 in patient and at-risk population samples employing RT-PCR assay system. As of date more than 330,000 samples have been analyzed and reported on, regularly within 24 hours.

Kochupurackal P Mohanakumar, PhD

FNASc, FAScT, FIAN